Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Impact of diagnosis-to-treatment interval on the outcome of patients with acute myeloid leukemia.
Journal: Annals of hematology
Published: November 18, 2025
Gilteritinib: An FMS-like tyrosine kinase 3/AXL tyrosine kinase inhibitor for the treatment of relapsed or refractory acute myeloid leukemia patients.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: April 28, 2020
Enasidenib in acute myeloid leukemia: clinical development and perspectives on treatment.
Journal: Cancer management and research
Published: May 13, 2019
Challenges of Fertility Sparing Ovarian Surgery Imposed by Krukenberg Tumors in Pregnancy.
Journal: Clinical medical reviews and case reports
Published: September 15, 2015
Showing 1-4 of 4
Last Updated: 09/26/2026